Trastuzumab-emtansina versus otros regímenes anti-HER-2 en el cáncer de mama HER-2 positivo precoz o irresecable o metastásico: revisión sistemática y metaanálisis en red

Trastuzumab-emtansina versus otros regímenes anti-HER-2 en el cáncer de mama HER-2 positivo precoz o irresecable o metastásico: revisión sistemática y metaanálisis en red

Objective. We aimed to study the efficacy and safety of trastuzumab-emtansine (T-DM1) versus other anti-HER2 therapies in HER2+ breast cancer (BC). Materials and Methods. We performed a network meta-analysis (NMA) of randomized controlled trials (RCTs). Our study focused on patients u...

Full description

Saved in:
Bibliographic Details
Main Authors: Agustín Ciapponi, Ariel Bardach, Carla Colaci, Federico Rodríguez Cairoli, Fernando Argento, Ernesto Korbenfeld, Sebastián García Martí
Format: Article
Language:Spanish
Published: Instituto Nacional de Salud 2024-03-01
Series:Revista Peruana de Medicina Experimental y Salud Pública
Subjects:
her2 genes
breast cancer
network meta-analysis
systematic review
trastuzumab emtansine
Online Access:https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/13351/5596
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/13351/5596

Similar Items